Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts. Show more
500 Cummings Center, Beverly, MA, 01915, United States
Market Cap
165M
52 Wk Range
$5.34 - $9.13
Previous Close
$6.06
Open
$6.06
Volume
203,669
Day Range
$6.02 - $6.27
Enterprise Value
62.93M
Cash
119.6M
Avg Qtr Burn
-943K
Insider Ownership
12.42%
Institutional Own.
76.87%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
